efegatran has been researched along with Hemorrhage in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|
1 trial(s) available for efegatran and Hemorrhage
| Article | Year |
|---|---|
Multicenter, dose-ranging study of efegatran sulfate versus heparin with thrombolysis for acute myocardial infarction: The Promotion of Reperfusion in Myocardial Infarction Evolution (PRIME) trial.
Topics: Adult; Aged; Anticoagulants; Antithrombins; Female; Hemorrhage; Heparin; Humans; Male; Middle Aged; Myocardial Infarction; Oligopeptides; Patient Selection; Recurrence; Regression Analysis; Treatment Failure | 2002 |